Video

John Sergent, MD: Autoimmune Disease is More Common Than You Think

Author(s):

Expert John Sergent shares insight on his best practices treating patients with autoimmune diseases.

There are certain struggles that come with an autoimmune disease diagnosis. Whether it's a rare disease like myositis or something more common like rheumatoid arthritis (RA) patient education is crucial, according to seasoned rheumatologist John Sergent.

In an interview with HCPLive®, John Sergent, MD, MACP, MACR, is a professor of medicine in the Division of Rheumatology & Immunology at Vanderbilt University Medical Center (VUMC) where he's been a member of faculty for 47 years.

He believes that if people–physicians and patients, alike–are educated on these diseases and realize that research is allowing more understanding of what triggers an autoimmune disease, it will help with treating patients.

"One big problem I have is people who, because of the fatigue and pain, sometimes can't work a full day," Sergent said. "They can work maybe 6 hours instead of 8. And a lot of times, it's very difficult to get companies to understand that. It's just very, very frustrating for them, and for me."

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
© 2024 MJH Life Sciences

All rights reserved.